7. Distribution of high-risk human papillomavirus genotypes and their association with cervical cytology in Kazakhstani women

Авторы

  • N.* Kadroldinova Department of Surgery, Nazarbayev University, Astana, Kazakhstan
  • T. Ukybassova Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan
  • B. Primbetov Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan
  • B. Imankulova Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan
  • S. Makhambetova Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan
  • M. Galym Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan
  • A. Batpanova Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan
  • D. Baktybayeva
  • K. Nurgaliyeva Clinical Academic Department of Laboratory medicine, pathology and genetics, CF “University Medical Center”, Astana, Kazakhstan https://orcid.org/0000-0002-9604-7991
  • Z. Zhumakanova Clinical Academic Department of Laboratory medicine, pathology and genetics, CF “University Medical Center”, Astana, Kazakhstan https://orcid.org/0009-0003-8834-4405
  • K. Kongrtay Department of Surgery, Nazarbayev University, Astana, Kazakhstan https://orcid.org/0000-0002-1405-2245
  • N. Kamzayeva Clinical Academic Department of Women’s Health, CF “University Medical Center”, Astana, Kazakhstan https://orcid.org/0009-0009-0229-2661

DOI:

https://doi.org/10.35805/BSK2025II007

Загрузки

Аннотация

Background. Precancerous lesions of the cervix in women of reproductive age are an urgent problem of modern medicine. Despite progress in understanding the molecular mechanisms of human papillomavirus mediated carcinogenesis and the introduction of screening and vaccination programs, the incidence of cervical cancer remains high worldwide. The aim of this study is to identify the prevalence and distribution of different cervical precancerous lesions. Materials and method. This is a cross-sectional study based on the University cluded 403 women of reproductive age (18-45 years). Two statistical analyses were used to compare differences between groups: the Kruskal–Wallis test and the Jonckheere– Terpstra test.

Results. Age of the patients, Body Mass Index, age at menarche and other variables are distributed similarly among different precancerous lesion groups, suggesting homogeneous distribution of study population among cervical cytological groups. Overall, 35.1% of patients were tested positive for high-risk human papillomavirus in our cohort. Among 12 high risk human papillomavirus genotypes, ems-16 was the most prevalent high-risk human papillomavirus genotype with prevalence of 11.4%, followed by emsRO with a prevalence of 6.6% each other and ems-33 that was present in 5.3% patients who tested positive for human papillomavirus.

Conclusion. among other Asian countries and underscores the value of ongoing regional surveillance to inform effective vaccination and screening policy.

Ключевые слова

Human papillomavirus, cervical precancerous lesions, cervical cancer, high-risk HPV genotypes

Библиографические ссылки

  1. Sung H, Ferlay J, Siegel RL, et al. *OREDO&DQFHU6WDWLVWLFV*/2-BOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 0D GRL caac.21660
  2. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mor-WDOLW RI FHUYLFDO FDQFHU LQ D worldwide analysis. Lancet Glob +HDOWK )HE HH GRL6;
  3. Aimagambetova G, Azizan A. Ep-idemiology of HPV Infection and HPV-Related Cancers in Kazakh-VWDQD5HYLHZ$VLDQ3DF-&DQFHU 3UHY 0D GRL$3-&3
  4. Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cer-vical screening on cervical cancer HOLPLQDWLRQDFRPSDUDWLYHPRGHOOLQJ analysis in 78 low-income and low-er-middle-income countries. Lan-FHW)HE GRL6
  5. Babi A, Issa T, Issanov A, et al. Preva-lence of high-risk human papilloma-virus infection among Kazakhstani women attending gynecological outpatient clinics. Int J Infect Dis. $XJ GRLM ijid.2021.06.006
  6. Aimagambetova G, Chan CK, Uky-bassova T, et al. Cervical cancer screening and prevention in Ka-zakhstan and Central Asia. J Med 6FUHHQ 0DU GRL
  7. Rizzo A, Moschese D, Salari F, et al. High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy. J Med Virol. -DQ H GRL jmv.29370
  8. Seyoum A, Seyoum B, Gure T, et al. High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethio-SLD6FL5HS-DQ GRLV
  9. Babi A, Issa T, Gusmanov A, et al. Prevalence of high-risk human papil-lomavirus infection and genotype dis-tribution among Kazakhstani women with abnormal cervical cytology. Ann 0HG'HF GRL
  10. Taskin MH, Nursal AF, Oruc MA, Kariptas E. Genotype Distribution and Prevalence of High-Risk Hu-man Papillomavirus Infection among Women in Samsun Province of Tur-key. Asian Pac J Cancer Prev. Jul 1 GRL APJCP.2022.23.7.2477
  11. World Health Organization. Electron-ic address swi. Human papillomavi-UXV YDFFLQHV :+2 SRVLWLRQ SDSHU May 2017-Recommendations. Vac-FLQH 2FW GRLMYDFFLQH
  12. Tanko NM, Linkov F, Bapayeva G, et al. Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding in Daily &OLQLFDO3UDFWLFH:KWKH$SSURDFK %8//(7,12)685*(5<,1.$=$.+67$1ɫ 79 to Patients Should Be Personal-L]HG"-3HUV0HG6HS GRLMSP
  13. Bapayeva G, Aimagambetova G, Is-sanov A, et al. The Effect of Stress, Anxiety and Depression on In Vitro Fertilization Outcome in Kazakhstani 3XEOLF&OLQLFDO6HWWLQJ$&URVV6HF-tional Study. J Clin Med. Mar 1 GRLMFP
  14. Aimagambetova G, Issanov A, Ter-zic S, et al. The effect of psycho-ORJLFDO GLVWUHVV RQ ,9) RXWFRPHV Reality or speculations? PLoS One. H GRL journal.pone.0242024
  15. Alrajjal A, Pansare V, Choudhury MSR, Khan MYA, Shidham VB. Squa-PRXV LQWUDHSLWKHOLDO OHVLRQV 6,/ LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda 6VWHP &WRMRXUQDO GRL&WRMRXUQDOBB
  16. Ukybassova T, Terzic M, Dotlic J, et al. Evaluation of Uterine Artery Em-EROL]DWLRQRQ0RPD6KULQNDJH5H-sults from a Large Cohort Analysis. Gynecol Minim Invasive Ther. Oct-'HF GRL GMIT.GMIT_50_19
  17. Na J, Li Y, Lu Q, Wang Y, Han S, Wang J. Investigating the impact of persistent HPV infection on recur-rence of lesions post-surgery for early-stage cervical cancer and re-ODWHG LQʗXHQFLQJ IDFWRUV )URQW 2Q-FRO GRL fonc.2025.1506521
  18. Wijeratne Y, Hapuachchige C. Surgi-cal Outcomes in Early-Stage Cervical Cancer Following Radical Hysterec-WRPLQD5HVRXUFH/LPLWHG6HWWLQJ The Experience of the National Can-cer Institute (Apeksha Hospital, Ma-haragama), Sri Lanka. Cureus. Oct H GRLFX-reus.47744
  19. Bogani G, Sopracordevole F, Cia-vattini A, et al. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. Eur J Cancer Prev. Nov GRL CEJ.0000000000000822
  20. Iacobone AD, Radice D, Sandri MT, et al. Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neopla-VLD 5HFXUUHQFH &DQFHUV %DVHO -XO GRLFDQ-cers13153664
  21. Jing Y, Wang T, Chen Z, et al. Phy-logeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China. Mol Med Rep. May GRL mmr.2018.8743
  22. Ye J, Zheng L, He Y, Qi X. Human papillomavirus associated cervical OHVLRQ SDWKRJHQHVLV DQG WKHUDSHX-tic interventions. MedComm (2020). 2FW H GRL mco2.368
  23. Winer RL, Hughes JP, Feng Q, Stern JE, Xi LF, Koutsky LA. Incident De-tection of High-Risk Human Papil-lomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years. -,QIHFW'LV6HS GRLLQIGLVMLZ
  24. Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing WKHRSWLPDO+39YDFFLQH7KHKHDOWK impact and economic value of the nonavalent and bivalent HPV vac-cines in 48 Gavi-eligible countries. ,QW-&DQFHU)HE GRLLMF
  25. Seyoum A, Assefa N, Gure T, Seyoum B, Mulu A, Mihret A. Prevalence and Genotype Distribution of High-Risk Human Papillomavirus In-fection Among Sub-Saharan Afri-FDQ :RPHQ $ 6VWHPDWLF 5HYLHZ and Meta-Analysis. Front Public +HDOWKGRL fpubh.2022.890880
  26. Satanova A, Bolatbekova R, Kukubassov Y, Ossikbayeva S, Kaidarova D. Vaccination Effective-ness against Human Papillomavirus in Kazakhstan. Asian Pac J Can-FHU 3UHY )HE GRL$3-&3 +DUOʖQJHU - 6RPPHU , *DUWOHKQHU G. [WHO Guideline for Screening and Treatment of Cervical Pre-Can-cerous Lesions for Cervical Cancer 3UHYHQWLRQ 6HFRQG (GLWLRQ@ *H-VXQGKHLWVZHVHQ-XO
  27. Nah EH, Cho S, Kim S, Cho HI. Hu-man Papillomavirus Genotype Dis-tribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings. Ann /DE 0HG 6HS GRLDOP
  28. Aimagambetova G, Babi A, Issa T, Is-sanov A. What Factors Are Associat-ed with Attitudes towards HPV Vacci-nation among Kazakhstani Women? Exploratory Analysis of Cross-Sec-tional Survey Data. Vaccines (Basel). 0D GRLYDF-cines10050824
  29. Luo Q, Zhang H, Zeng X, Han N, Ma =/XR++39VSHFLʖFLWDQGPXOWL-ple infections and association with cervical cytology in Chongqing, Chi-QD D FURVVVHFWLRQDO VWXG %0& ,QIHFW 'LV $XJ GRLV
  30. Wei L, Ma L, Qin L, Huang Z. The prev-alence and genotype distribution of human papillomavirus among wom-en in Guangxi, southern China. Infect $JHQW&DQFHU$SU GRLV 5HQ;+DR<:X%HWDO(IʖFDFRI prophylactic human papillomavirus vaccines on cervical cancer among WKH$VLDQSRSXODWLRQ$PHWDDQDO-VLV)URQW0LFURELRO GRLIPLFE
  31. Tao X, Austin RM, Yu T, et al. Risk VWUDWLʖFDWLRQ IRU FHUYLFDO QHRSODVLD using extended high-risk HPV ge-notyping in women with ASC-US cy-WRORJ $ ODUJH UHWURVSHFWLYH VWXG from China. Cancer Cytopathol. Apr GRL cncy.22536

Опубликован

2025-06-30

Выпуск

№ 2 (2025)

Раздел

Статьи